Literature DB >> 1327854

Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species.

H Tajima1, K Matsumoto, T Nakamura.   

Abstract

Hepatocyte growth factor (HGF), a humoral mediator for regeneration of liver and kidney, possesses multiple biological activities. To investigate target cell specificity and to examine whether multiple actions of HGF are related to properties of the HGF receptor on target cells, we examined the effects of HGF on cell growth and motility and analyzed the HGF receptor in various species of cells. HGF stimulated growth and DNA synthesis of PAM212 (naturally immortalized mouse keratinocytes), Mv1Lu (mink lung epithelia), and A431 (human epidermoid carcinoma) cells, as well as mature hepatocytes, but inhibited those of IM-9 (human B-lymphoblasts). Conversely, HGF had a marked stimulatory effect on cell motility of MDCK (Mardin-Darby canine kidney epithelia) cells, but not on their growth. Also, HGF enhanced the motility of various species of cells, including A431, PAM212, HepG2 (human hepatoma), KB (human epidermoid carcinoma), and J-111 (human monocytes) cells. Scatchard analysis of 125I-HGF binding to hepatocytes indicated that the cells expressed both high- and low-affinity binding sites for HGF with Kd values of 23 and 260 pM, respectively. High-affinity HGF receptor with Kd values of 20-25 pM was detected at 40-720 sites/cell in MDCK, A431, PAM212, Lu99, and IM-9 cells, but not in fibroblasts and hematopoietic cells. In contrast, low-affinity binding sites were detected in all cell lines examined, even in those not responsive to HGF. Northern blots revealed that cells possessing a high-affinity HGF receptor expressed c-MET/HGF receptor mRNA. Therefore, HGF probably regulates both cell growth and motility of various types of epithelial cells and some types of mesenchymal cells. The multiple biological activities of HGF may be exerted through a high-affinity HGF receptor linked to multiple distinct intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327854     DOI: 10.1016/0014-4827(92)90095-p

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  27 in total

1.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge.

Authors:  Maria Bokhari; Ross J Carnachan; Neil R Cameron; Stefan A Przyborski
Journal:  J Anat       Date:  2007-08-15       Impact factor: 2.610

3.  Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis.

Authors:  K Fazekas; O Csuka; I Köves; E Rásó; J Tímár
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Expression of p53/HGF/c-met/STAT3 signal in fetuses with neural tube defects.

Authors:  Maria Trovato; Maria D'Armiento; Luca Lavra; Alessandra Ulivieri; Roberto Dominici; Enrica Vitarelli; Maddalena Grosso; Raffaella Vecchione; Gaetano Barresi; Salvatore Sciacchitano
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

5.  Regulation of Epithelial-to-Mesenchymal Transition Using Biomimetic Fibrous Scaffolds.

Authors:  Anitha Ravikrishnan; Tugba Ozdemir; Mohamed Bah; Karen A Baskerville; S Ismat Shah; Ayyappan K Rajasekaran; Xinqiao Jia
Journal:  ACS Appl Mater Interfaces       Date:  2016-07-05       Impact factor: 9.229

6.  The tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells.

Authors:  Rongyang Dai; Juanjuan Li; Jing Fu; Yao Chen; Ruoyu Wang; Xiaofang Zhao; Tao Luo; Junjie Zhu; Yibin Ren; Jie Cao; Youwen Qian; Ning Li; Hongyang Wang
Journal:  J Biol Chem       Date:  2012-09-28       Impact factor: 5.157

7.  Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma.

Authors:  Yakup Bozkaya; Nebi Serkan Demirci; Alican Kurtipek; Gökmen Umut Erdem; Nuriye Yildirim Ozdemir; Nurullah Zengin
Journal:  Mol Clin Oncol       Date:  2017-06-08

8.  Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.

Authors:  Yiru Xu; Jin Zhou; Thomas E Carey; Jonathan B McHugh; John J Voorhees; Gary J Fisher
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

9.  Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression.

Authors:  Satoru Sugie; Shoichiro Mukai; Koji Yamasaki; Toyoharu Kamibeppu; Hiromasa Tsukino; Toshiyuki Kamoto
Journal:  Hum Cell       Date:  2015-08-07       Impact factor: 4.174

10.  Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621.

Authors:  Neil R Michaud; Jitesh P Jani; Stephen Hillerman; Konstantinos E Tsaparikos; Elsa G Barbacci-Tobin; Elisabeth Knauth; Henry Putz; Mary Campbell; George A Karam; Boris Chrunyk; David F Gebhard; Larry L Green; Jinghai J Xu; Margaret C Dunn; Tim M Coskran; Jean-Martin Lapointe; Bruce D Cohen; Kevin G Coleman; Vahe Bedian; Patrick Vincent; Shama Kajiji; Stefan J Steyn; Gary V Borzillo; Gerrit Los
Journal:  MAbs       Date:  2012-09-24       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.